‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply




Broman Niklas, Feuth Thijs, Oksi Jarmo; COVIDSTORM study group

PublisherElsevier B.V.

2022

 Clinical Microbiology and Infection

Clinical Microbiology and Infection

CLIN MICROBIOL INFEC

28

11

1520

1521

1469-0691

DOIhttps://doi.org/10.1016/j.cmi.2022.06.028

https://doi.org/10.1016/j.cmi.2022.06.028

https://research.utu.fi/converis/portal/detail/Publication/176385949



Last updated on 26/11/2024 04:31:34 PM